Changes in general practitioners' attitudes toward COVID-19 vaccination after first interim results: a longitudinal approach in France.
COVID-19
healthcare workers
infodemic
longitudinal approaches
vaccine acceptance
vaccine safety and efficacy
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
03 10 2021
03 10 2021
Historique:
pubmed:
14
7
2021
medline:
16
9
2021
entrez:
13
7
2021
Statut:
ppublish
Résumé
We assessed whether the a priori acceptance by French general practitioners (GPs) of COVID-19 vaccines changed after the announcements about them in November 2020. In all, between two surveys in October-November and in November-December 2020, acceptance of COVID-19 vaccines increased among 16.9% of GPs and decreased among 23.0%. Among those with high acceptance in October-November (52.5%), 11.6% became hesitant-reluctant in November-December; in those with initial hesitancy-reluctance (24.6%), 15.2% showed high acceptance. Deteriorating acceptance was significantly associated with GPs' distrust in the Ministry of Health and a priori concerns about the safety of vaccines developed during an epidemic; the reverse was found for improving acceptance. In addition, better acceptance was more likely among GPs who perceived the medical severity of COVID-19 to be high and was less common among women. During a severe pandemic, GPs' trust in health institutions and perception of safety issues remain important predictors of their attitudes toward new vaccines. Vigilance is needed regarding health professionals' reactions to events that may cast doubt on the safety or efficacy of certain COVID-19 vaccines. Personalized approaches should be considered and tested to address their concerns as the situation and knowledge evolve.
Identifiants
pubmed: 34254880
doi: 10.1080/21645515.2021.1943990
pmc: PMC8437498
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3408-3412Références
Int J Qual Stud Health Well-being. 2020 Dec;15(1):1757336
pubmed: 32400299
EBioMedicine. 2015 Jun 23;2(8):891-7
pubmed: 26425696
Vaccines (Basel). 2020 Dec 30;9(1):
pubmed: 33396832
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Euro Surveill. 2021 Jan;26(3):
pubmed: 33478623
Vaccine. 2010 Mar 24;28(15):2743-8
pubmed: 20117271
Vaccine. 2014 Apr 25;32(20):2281-7
pubmed: 24631097
Healthcare (Basel). 2020 Dec 03;8(4):
pubmed: 33287260
Acta Inform Med. 2020 Dec;28(4):241-247
pubmed: 33627924
Lancet Public Health. 2021 Apr;6(4):e195-e196
pubmed: 33556329
Soc Sci Med. 2020 Nov;265:113414
pubmed: 33038683
BMC Fam Pract. 2021 Feb 14;22(1):36
pubmed: 33583410
J Hosp Infect. 2021 Feb;108:168-173
pubmed: 33259883